The Ottawa Minimally Invasive Gynecology Research Group is located at the Riverside Campus of The Ottawa Hospital and focuses on the study of benign complex gynecologic conditions with experience in medical clinical trials and surgical gynaecology evaluation.


Current studies include:

M12-815: A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women.  Abbie International

National Uterine Fibroid Registry Project

A Randomized, placebo-controlled, parallel group, multi-center study to evaluate the efficacy and safety of Ulipristal acetate for the intermittent treatment of abnormal uterine bleeding associated with leiomyomas.  Actives (COMPLETED)

Planned Early Discharge After Laparoscopic hysterectomy (PEDAL) Study:  A pilot prospective observational study.  Investigator led with funding from TOHAMO.  (COMPLETED)

Characteristics of Immune Mechanisms Involved in Pathophysiology of Endometriosis. Collaboration with Dr. Chandrakant Tayade, DVM,MVSc,PhD, Dept of Biomedical and Molecular Sciences, Queen's University.  

Hysterectomy Approaches in a Canadian Tertiary Hospital. 7 years in review.   (COMPLETED)